Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1653 1759
This examiner grants 12% of resolved cases
Natalie NMN Iannuzo examines applications in Tech Center 1700 and Art Unit 1653. The examiner has 40 resolved cases, with an allowance rate of 12.5 percent. This rate serves as a baseline for applicants to understand the likelihood of a grant. The median days to allowance is 1227, which indicates the time typically required to reach a final allowance under this examiner's review.
The interview lift is 71.4 percent, which is a substantial figure compared to the 12.5 percent allowance rate. This lift suggests that applications involving an interview are much more likely to be allowed than those that do not. Given the 1227-day median pendency, practitioners should consider the 71.4 percent lift as a critical component of their prosecution strategy. In Art Unit 1653, the 40 resolved cases highlight that while the 12.5 percent allowance rate is low, direct engagement with the examiner can significantly improve the chances of success.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18183815 | METHODS AND COMPOSITIONS FOR THE GENERATION OF PROGRAMABLE POST-TRANSLATIONAL PROTEIN MODIFICATION AND HYDROLYSIS | Final Rejection | The Regents of the University of California |
| 17429299 | MATERIALS AND METHODS FOR THE PREPARATION OF BACTERIAL CAPSULAR POLYSACCHARIDES | Non-Final OA | The Regents of the University of California |
| 18095839 | Methods for Improving Resolution of Heterodimeric Proteins from Impurities Using Affinity Chromatography | Final Rejection | Regeneron Pharmaceuticals, Inc. |
| 17933174 | DOSAGE FORMS FOR THE DELIVERY OF A PROBIOTIC | Final Rejection | Kenvue Brands LLC |
| 18042378 | Composition For Treating or Preventing Clostridium Difficile Infection | Non-Final OA | Seoul National University R&DB Foundation |
| 18329130 | METHODS FOR DETECTING ZEROVALENT NANOPARTICLE-MEDIATED OXIDATIVE STRESS IN CYANOBACTERIA | Final Rejection | Morgan State University |
| 16811019 | Processes for Producing Fermentation Products | Non-Final OA | NOVOZYMES A/S |
| 18653590 | OCULAR ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE THEREOF | Non-Final OA | The University of Hong Kong |
| 18259613 | LOW LIPID CONTENT OAT PROTEIN COMPOSITION WITHOUT TRACES OF ORGANIC SOLVENT OR SURFACTANT | Final Rejection | ROQUETTE FRERES |
| 17999437 | AN APPARATUS COMPRISING MICROFLUIDIC PROTEIN-BASED SENSORS AND METHODS OF USING SAME | Non-Final OA | UNIVERSITY OF MARYLAND, BALTIMORE COUNTY |
| 18934525 | ClyRD, A NOVEL CHIMERIC ENDOLYSIN FROM CLOSTRIDIUM PERFRINGENS PHAGES WITH ENHANCED ANTIBACTERIAL ACTIVITY | Non-Final OA | FOUNDATION FOR RESEARCH AND BUSINESS, SEOUL NATIONAL UNIVERSITY OF SCIENCE AND TECHNOLOGY |
| 18083656 | METHODS AND KITS FOR ASSAYING A LARGE FLUID VOLUME USING FLOW CYTOMETRY | Non-Final OA | HACH COMPANY |
| 18577315 | PROCESS TO PRODUCE POLYHYDROXYALKANOATES FROM SEAWEED | Non-Final OA | C Sea Solutions Pty Ltd |
| 17633930 | COMPOSITIONS AND METHODS FOR SUPPRESSING PATHOGENIC ORGANISMS | Final Rejection | Vedanta Biosciences, Inc. |
| 18572696 | CANNABINOID-CONTAINING FORMULA FOR SKIN CARE | Non-Final OA | LONDON PHARMACEUTICALS AND RESEARCH CORPORATION |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy